chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 22Nov02 concerning a group of vaccinees less than 4 year old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicated that a 12 month old female was inadvertently administered Fluvirin IM on 15Nov02. The vaccinee experienced no adverse reactions.  Cross reference: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200805, PJP200200863, PJP200200864, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP200200875, PJP200200876, PJP200200877.
Age: 0.58
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 22Nov02 concerning a group of vaccinees less than 4 year old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicated that a 7 month old male vaccinee was inadvertently administered Fluvirin IM on 15Nov02. The vaccinee experienced no adverse reaction. Cross reference: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200805, PJP200200864, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP200200875, PJP200200876, PJP200200877.
Age: 21.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/22/02, concerning a group of vaccinees less than 4 years old of unknown demography who inadvertently received Fluvirin from approximately 11/07/02 onwards. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update (1) 12/10/02: A follow up report was received on 12/10/02, indicating that a 21 month old female vaccinee was inadvertently administered Fluvirin intramuscularly on 11/15/02. the vaccinee experienced no adverse reactions. Cross reference: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857,PJP200200858, PJP20020859, PJP200200860, PJP200200861, PJP200200862, PJP200200863, PJP200200805, PJP200200865, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP200200875, PJP200200876 andPJP200200877.
Age: 3.5
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/22/02, concerning a group of vaccinees less than 4 years old of unknown demography who inadvertently received Fluvirin from approximately 11/07/02 onwards. There was no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update (1) 12/10/02: A report was received from a health care professional on 12/10/02, indicating that a 3 and a half year old female vaccine was inadvertently administered Fluvirin intramuscularly on 11/12/02. The vaccinee experienced no adverse reaction. Cross reference: PJP20200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP2002862, PJP200200863, PJP200200864, PJP200200805, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP200200875, PJP200200876, PJP200200877.
Age: 1.5
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/22/02, concerning a group of vaccinees less than 4 years old of unknown demography who inadvertently received Fluvirin from approximately 11/07/02 onwards. There was no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update (1) 12/10/02: A follow up was received from a health care professional on 12/10/02 indicating that a 18 month old male vaccinee was inadvertently administered Fluvirin intramuscularly on 11/12/02. The vaccinee experienced no adverse event. Cross reference with: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200863, PJP200200864, PJP200200865, PJP200200805, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP200200875, PJP20020876, PJP200200877.
Age: 1.75
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/22/02, concerning a group of vaccinees less than 4 years old of unknown demography who inadvertently received Fluvirin from approximately 11/07/02 onwards. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update (1) 12/10/02: A follow up report was received by a health professional indicating that a 21 month old male vaccinee was inadvertently administered Fluvirin intramuscularly on 11/12/02. Cross reference with: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200863, PJP200200864, PJP200200865, PJP200200866, PJP200200805, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP200200875, PJP200200876, PJP200200877.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 11/22/02, concerning a group of vaccinees less than 4 years old of unknown demography who inadvertently received Fluvirin from approximately 11/07/02 onwards. There were no reported adverse events. No further information reported. There was insufficient information to determine the reporter's causality assessment. Update (1) 12/10/02: A follow up report was received by a health professional indicating that a 2 year old female vaccinee was inadvertently administered Fluvirin intramuscularly on 11/12/02. Cross reference with: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200863, PJP200200864, PJP200200865, PJP200200866, PJP200200867, PJP200200805, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP200200875, PJP200200876, PJP200200877.
Age: 3.5
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 22Nov02 concerning a group of vaccinees less than 4 year old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicating that a 3 and half year old male vaccinee was inadvertently administered Fluvirin IM on 14Nov02. The vaccinee experienced no adverse reaction. Cross reference: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200805, PJP200200864, PJP200200866, PJP200200867, PJP200200868, PJP200200805, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP200200875, PJP200200876, PJP200200877.
Age: 1.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 22Nov02 concerning a group of vaccinees less than 4 year old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicating that a 12 month old female vaccinee was inadvertently administered Fluvirin IM on 15Nov02. The vaccinee experienced no adverse reaction. Cross reference: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200805, PJP200200864, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200805, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP200200875, PJP200200876, PJP200200877.
Age: 0.92
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 22Nov02 concerning a group of vaccinees less than 4 year old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicating that a 11 month old female vaccinee was inadvertently administered Fluvirin IM on 15Nov02. The vaccinee experienced no adverse reaction. Cross reference: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200805, PJP200200864, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200805, PJP200200872, PJP200200873, PJP200200874, PJP200200875, PJP200200876, PJP200200877.
Age: 2.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 22Nov02 concerning a group of vaccinees less than 4 year old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicating that a 30 month old female vaccinee was inadvertently administered Fluvirin IM on 12Nov02. The vaccinee experienced no adverse reaction. Cross reference: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200805, PJP200200864, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200805, PJP200200873, PJP200200874, PJP200200875, PJP200200876, PJP200200877.
Age: 0.92
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 22Nov02 concerning a group of vaccinees less than 4 year old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicating that a 11 month old male vaccinee was inadvertently administered Fluvirin IM on 12Nov02. The vaccinee experienced no adverse reaction. Cross reference: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200805, PJP200200864, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200805, PJP200200874, PJP200200875, PJP200200876, PJP200200877.
Age: 3.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 22Nov02 concerning a group of vaccinees less than 4 year old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicating that a 3 year old female vaccinee was inadvertently administered Fluvirin IM on 12Nov02. The vaccinee experienced no adverse reaction. Cross reference: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200805, PJP200200864, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200805, PJP200200875, PJP200200876, PJP200200877.
Age: 1.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 22Nov02 concerning a group of vaccinees less than 4 year old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicating that 12 month old female vaccinee was inadvertently administered Fluvirin IM on 14Nov02. The vaccinee experienced no adverse reaction. Cross reference: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200805, PJP200200864, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP200200805, PJP200200876, PJP200200877.
Age: 1.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 22Nov02 concerning a group of vaccinees less than 4 year old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicating that 12 month old male vaccinee was inadvertently administered Fluvirin IM on 14Nov02. The vaccinee experienced no adverse reaction. Cross reference: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200805, PJP200200864, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP200200875, PJP200200805, PJP200200877.
Age: 2.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a healthcare professional on 22Nov02 concerning a group of vaccinees less than 4 year old of unk demography who inadvertently received Fluvirin from approx 07Nov02 onwards. From 07Nov02 Fluvirin was administered to vaccinees less than 4 years old. There were no reported adverse events. There was insufficient information to determine the reporter's causality assessment. Update 1 10Dec02: A follow up report was received from a health professional indicating that 24 month old male vaccinee was inadvertently administered Fluvirin IM on 14Nov02. The vaccinee experienced no adverse reaction. Cross reference: PJP200200848, PJP200200849, PJP200200850, PJP200200851, PJP200200852, PJP200200853, PJP200200854, PJP200200855, PJP200200856, PJP200200857, PJP200200858, PJP200200859, PJP200200860, PJP200200861, PJP200200862, PJP200200805, PJP200200864, PJP200200866, PJP200200867, PJP200200868, PJP200200869, PJP200200870, PJP200200871, PJP200200872, PJP200200873, PJP200200874, PJP200200875, PJP200200876, PJP200200805.
Age: 66.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site erythema, Injection site vesicles
Clinical narrative: A report received from a health care professional on 12Dec02, concerning a 66 year old female vaccinee who experienced a blister at the injection site and redness 1 day after receiving Fluvirin on 17Oct02. On 18Oct02, the vaccinee experienced a blister at the injection site and redness 1 day after receiving Fluvirin. The vaccinee was treated with betamethasone dipropionate and celecoxib. At the time of reporting the vaccinee had not yet recovered. There was insufficient information to determine the reporter's causality assessment. Update 1, 30Jan03: A report was received from a health care professional indicating that Fluvirin vaccine was received on 18Oct02. The blister at the injection site continued until the end of December 2002. The event was reported as resolved.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received on 25Oct02 concerning a 33 year old vaccinee and approx 15 clinic staff members who were administered a Fluvirin injection in error in Oct02. On an unk date in Oct02, the vaccinee and approx 15 staff members were administered Fluvirin with 1/2 inch needles. The reporter suspected that the staff members may have received the vaccine via a SC and not an IM route. The reporter has assessed the relationship of the vaccines to the event unclassifiable. A report  received from a health care professional on 13Dec02 concerning a 54 year old female vaccine who was administered Fluvirin SC on 08Oct02. On 08Oct02, the vaccinee was inadvertently administered Fluvirin SC. The outcome of the event was unk. Ref: PJP200200657, PJP200200883, PJP2002008884, PJP200200885, PJP200200889, PJP200200890.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received on 25Oct02 concerning a 33 year old vaccinee and approx 15 clinic staff members (demography unk) who were administered a Fluvirin injection by inappropriate route in error in Oct02. On an unk date in Oct02, the vaccinee and approx 15 staff members were administered Fluvirin with 1/2 inch needles. The reporter suspected that the staff members may have received the vaccine via a SC and not an IM route. No adverse events were reported. The reporter has assessed the relationship of the vaccines to the event unclassifiable. Update 1 13Dec02: An update report was received received from a health care professional on 13Dec02 concerning a 50 year old female vaccine who was administered Fluvirin SC on 08Oct02. On 08Oct02, the vaccinee was inadvertently administered Fluvirin SC. The outcome of the event was unk. No further information was provided. Ref: PJP200200657, PJP200200882, PJP200200890, PJP200200884, PJP200200885, PJP200200889.
Age: 49.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received on 25Oct02 concerning a 33 year old vaccinee and approx 15 clinic staff members (demography unk) who were administered a Fluvirin injection by inappropriate route in error in Oct02. On an unk date in Oct02, the vaccinee and approx 15 staff members were administered Fluvirin with 1/2 inch needles. The reporter suspected that the staff members may have received the vaccine via a SC and not an IM route. No adverse events were reported. The reporter has assessed the relationship of the vaccines to the event unclassifiable. Update 1 13Dec02: An update report was received received from a health care professional on 13Dec02 concerning a 49 year old female vaccine who was administered Fluvirin SC on 08Oct02. On 08Oct02, the vaccinee was inadvertently administered Fluvirin SC. The outcome of the event was unk. No further information was provided. Ref: PJP200200657, PJP200200883, PJP200200882, PJP200200885, PJP200200889, PJP200200890.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received on 25Oct02 concerning a 33 year old vaccinee and approx 15 clinic staff members (demography unk) who were administered a Fluvirin injection by inappropriate route in error in Oct02. On an unk date in Oct02, the vaccinee and approx 15 staff members were administered Fluvirin with 1/2 inch needles. The reporter suspected that the staff members may have received the vaccine via a SC and not an IM route. No adverse events were reported. The reporter did not have further details (name, age, pregnancy, medical/drug history) of other staff members. The reporter has assessed the relationship of the vaccines to the event unclassifiable. Update 1 13Dec02: An update report was received received from a health care professional on 13Dec02 concerning a 49 year old female vaccine who was administered Fluvirin SC on 08Oct02. On 08Oct02, the vaccinee was inadvertently administered Fluvirin SC. The outcome of the event was unk. No further information was provided. Ref: PJP200200657, PJP200200883, PJP200200882, PJP200200885, PJP200200889, PJP200200890.
Age: 40.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received on 25Oct02 concerning a 33 year old vaccinee and approx 15 clinic staff members (demography unk) who were administered a Fluvirin injection by inappropriate route in error in Oct02. On an unk date in Oct02, the vaccinee and approx 15 staff members were administered Fluvirin with 1/2 inch needles. The reporter suspected that the staff members may have received the vaccine via a SC and not an IM route. No adverse events were reported.  The reporter has assessed the relationship of the vaccines to the event unclassifiable. Update 1 13Dec02: An update report was received received from a health care professional on 13Dec02 concerning a 40 year old female vaccine who was administered Fluvirin SC on 08Oct02. On 08Oct02, the vaccinee was inadvertently administered Fluvirin SC. The outcome of the event was unk. Ref: PJP200200657, PJP200200882, PJP200200883, PJP200200884, PJP200200885, PJP200200890.
Age: 38.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report received on 25Oct02 concerning a 33 year old vaccinee and approx 15 clinic staff members (demography unk) who were administered a Fluvirin injection by inappropriate route in error in Oct02. On an unk date in Oct02, the vaccinee and approx 15 staff members were administered Fluvirin with 1/2 inch needles. The reporter suspected that the staff members may have received the vaccine via a SC and not an IM route. No adverse events were reported. The reporter has assessed the relationship of the vaccines to the event unclassifiable. Update 1 13Dec02: An update report was received received from a health care professional on 13Dec02 concerning a 38 year old female vaccine who was administered Fluvirin SC on 08Oct02. On 08Oct02, the vaccinee was inadvertently administered Fluvirin SC. The outcome of the event was unk. Ref: PJP200200657, PJP200200882, PJP200200883, PJP200200884, PJP200200885, PJP200200889.
Age: 69.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error
Clinical narrative: A report was received from a health care professional on 21Nov02 concerning a 11 vaccinees between the ages of  56 and 84 years who were inadvertently administered 1ml  Fluvirin on an unreported date. On an unreported date a 11 vaccinees were inadvertently administered 1ml Fluvirin.  No adverse events were reported. There was insufficient information to determine the reporters causality assessment. Update 1 31Dec02: A follow up report was received from a health care professional indicated that a 69 year old female vaccine was inadvertently administered  1.0ml Fluvirin on 21Nov02. Cross Ref with: PJP200200806, PJP200200906, PJP200200905, PJP200200904, PJP200200903, PJP200200902, PJP200200901, PJP200200900, PJP200200898, PJP200200907.
Age: 74.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error, Overdose
Clinical narrative: A report was received from a health care professional on 11/21/2002 concerning eleven vaccinees between the ages of 56 and 64 years who were inadvertently administered 1ml Fluvirin on an unreported date. On an unreported date eleven vaccinees were inadvertently administered 1ml Fluvirin, No adverse reaction was reported. There was insufficient information to determine the reporters causality assessment. Update1. 12/31/2002: A Follow up report was received from a health care professional indicated that a 74 year old male vaccinee was inadvertently administered 1.0ml Fluvirin on 11/21/2002. Cross Reference with: PJP200200806, PJP200200906, PJP200200905, PJP200200904, PJP200200903, PJP200200902, PJP200200901, PJP200200899, PJP200200898, PJP200200907.
Age: 81.0
Sex: F
Vaccine: FLU3
Symptoms: Medication error, Overdose
Clinical narrative: A report was received from  a health care professional on 11/21/2002 concerning eleven vaccinees between the ages of 56-64 years who were inadvertently administered 1ml Fluvirin on an unreported date. On an unreported date eleven vaccinees were inadvertently administered 1ml Fluvirin. No adverse reaction was reported. There was insufficient information to determine the reporters causality assessment. Update1. 12/31/2002: A follow up report was received form a health care professional indicated that a 81 year old female vaccinee was inadvertently administered 1ml Fluvirin on 11/21/2003. Cross Reference with: PJP200200806, PJP200200906, PJP200200905, PJP200200904, PJP200200903, PJP200200902, PJP200200900, PJP200200899, PJP200200898, PJP200200907.
Age: 84.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error, Overdose
Clinical narrative: A report was received from a healthcare professional on 11/21/2002 concerning eleven vaccinees between the ages of 56-84 years who inadvertently were administered 1.0ml Fluvirin on an unreported date. On an unreported date eleven vaccinees were inadvertently administered 1.0ml Fluvirin. No adverse reaction was reported. There was insufficient information to determine the reporters causality assessment. Update1. 12/31/2002:  A follow up report was received from a health care professional indicated that a 84 year old male vaccinee was  inadvertently administered 1.0ml Fluvirin on 11/21/2002. Cross Reference with: PJP200200806, PJP200200906, PJP200200905, PJP200200904, PJP200200903, PJP200200901, PJP200200900, PJP200200899, PJP200200898, PJP200200907.
Age: 64.0
Sex: M
Vaccine: FLU3
Symptoms: Medication error, Overdose
Clinical narrative: A report was received from a health care professional on 11/21/2002 concerning eleven vaccinees between the ages of 56-84 years who were inadvertently administered 1.0ml Fluvirin on an unreported date. On an unreported date, eleven vaccinees were inadvertently administered 1ml Fluvirin. No adverse reaction was reported. There was insufficient information to determine the reporters causality assessment. Update1. 12/31/2002: A follow up report was received from a health care professional indicated that a 64 year old male vaccinee was inadvertently administered 1.0ml Fluvirin on 11/21/2002. Cross Reference with: PJP200200806, PJP200200906, PJP200200905, PJP200200904, PJP200200902, PJP200200901, PJP200200900, PJP200200899, PJP200200898, PJP200200907.
Age: 63.0
Sex: F
Vaccine: TYP, YF
Symptoms: Chills, Injection site pain, Pruritus, Urticaria
Clinical narrative: 1/12/05 2:30p onset of chills, 1/13/05 itching of arm, 1/14/05 Whelp with itching, 1/15/05 extended whelp severe itching, 1/16/05 arm throbbed during night, 1/17/05 went to urgent care center Motrin and Benadryl given, 1/20/05 Allegra per Dr.
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Eczema, Lymphadenopathy, Rash, Sarcoma, Similar reaction on previous exposure to drug
Clinical narrative: After 2 mo (vaccines x7) Pt developed sleeping problems, discussed at 4mo appt. At which time pt got (shots x 7) at 6 months check up pt had dry eczema on trunk and faint rash and swollen lymph node under right arm. Develops into N/R sarcoma of peripheral nerve sheath. Pt had 2 month shots, 4 month shorts, 6 months he wasn't well, no others given. Death Certificate received which revealed COD as metastatic epitheloid sarcoma.
Sex: M
Vaccine: DTAP, HBHEPB, IPV, PNC
Symptoms: Sleep disorder
Clinical narrative: After 2 mo (vaccines x7) Pt developed sleeping problems, discussed at 4mo appt. At which time pt got (shots x 7) at 6 months check up pt had dry eczema on trunk and faint rash and swollen lymph node under right arm. Develops into N/R sarcoma of peripheral nerve sheath. Pt had 2 month shots, 4 month shorts, 6 months he wasn't well, no others given. Death Certificate received which revealed COD as metastatic epitheloid sarcoma.
Age: 1.08
Sex: F
Vaccine: PNC, VARCEL
Symptoms: Coordination abnormal, Hypoxia, Nervous system disorder, Paraplegia, Strabismus
Clinical narrative: Information has been received from a physician concerning an approximately 13 month old previously healthy female with no medical history who on 7/10/03, at 12 months of age, was vaccinated with a dose of varicella virus vaccine live (lot # 641709/0330M). Concomitant vaccinations on that same day included a dose of pneumococcal 4 6B 9V 14 18C 19F 23F conjugate vaccine. The physician reported that in August 2003, the patient presented to his office with numerous neurological problems including head deviation to her side which progressed to ataxia and crossing of her eyes. By the end of 2003, the patient's initial symptoms resolved on their own. In 2004, the patient's symptoms returned and in April 2004 she was admitted to a hospital and placed on a ventilator. At the time of this report, the physician indicated that the patient remained hospitalized, was a paraplegic, was still ventilator dependent and her current status was that of severe neurological devastation. The reporting physician was unsure if the patient's events were vaccine related. The reporting physician also considered the ataxia, crossing eyes, ventilator dependent, paraplegia, and severe neurological devastation to be disabling. Additional information has been requested.
Age: 1.08
Sex: F
Vaccine: PNC, VARCEL
Symptoms: Torticollis
Clinical narrative: Information has been received from a physician concerning an approximately 13 month old previously healthy female with no medical history who on 7/10/03, at 12 months of age, was vaccinated with a dose of varicella virus vaccine live (lot # 641709/0330M). Concomitant vaccinations on that same day included a dose of pneumococcal 4 6B 9V 14 18C 19F 23F conjugate vaccine. The physician reported that in August 2003, the patient presented to his office with numerous neurological problems including head deviation to her side which progressed to ataxia and crossing of her eyes. By the end of 2003, the patient's initial symptoms resolved on their own. In 2004, the patient's symptoms returned and in April 2004 she was admitted to a hospital and placed on a ventilator. At the time of this report, the physician indicated that the patient remained hospitalized, was a paraplegic, was still ventilator dependent and her current status was that of severe neurological devastation. The reporting physician was unsure if the patient's events were vaccine related. The reporting physician also considered the ataxia, crossing eyes, ventilator dependent, paraplegia, and severe neurological devastation to be disabling. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: MMR
Symptoms: Oedema peripheral, Pruritus, Swelling face, Urticaria
Clinical narrative: Information has been received from a physician concerning a 5 year old male with asthma, speech delay, and sensory issues in early childhood and no drug allergies who a week or two ago was vaccinated with a second dose of MMR. Concomitant therapy included pimecrolimus, alclometasone dipropionate , montelukast sodium, and citirizine hydrochloride. Subsequently, within 10 minutes, he experienced itchy hands, swelling, generalized hives and swelling of the face. It was noted that there was no respiratory symptoms. The patient was treated with epinephrine and diphenhydramine HCl, both by injection. The condition resolved while in the office with no further episodes. It was noted that the child received first dose of MMR at one year of age with no adverse symptoms. The reporter considered itchy hands, swelling, generalized hives, and swelling of the face to be other important medical events (OMIC). Additional information has been requested.
Age: 71.0
Sex: F
Vaccine: PPV
Symptoms: Cellulitis, Chills, Injection site erythema, Injection site hypersensitivity, Injection site induration
Clinical narrative: Initial and follow up information has been received from a physician concerning a 70 year old female radiologist who was vaccinated on 11/19/04 with a dose of pneumococcal 23v polysaccharide vaccine (lot # 650084/0605P; previously reported as 0573P). Subsequently, on an unspecified date, the patient developed cellulitis at the injection site described as a extremely bad local reaction with a high fever and severe redness the size of an orange. Follow up information also indicated that the patient developed severe induration, erythema, and swelling at the injection site followed by shaking chills, fever, and local cellulitis. There was no illness at the time of vaccination. It was reported that the patient was seen as an outpatient and was treated with an oral antibiotics. It was also reported that the patient recovered on an unspecified date. The reporter considered the patient's experiences to be an important medical event (OMIC). There was no product quality complaint involved. Additional information has been requested.
Age: 71.0
Sex: F
Vaccine: PPV
Symptoms: Injection site oedema, Injection site reaction, Pyrexia, Tremor
Clinical narrative: Initial and follow up information has been received from a physician concerning a 70 year old female radiologist who was vaccinated on 11/19/04 with a dose of pneumococcal 23v polysaccharide vaccine (lot # 650084/0605P; previously reported as 0573P). Subsequently, on an unspecified date, the patient developed cellulitis at the injection site described as a extremely bad local reaction with a high fever and severe redness the size of an orange. Follow up information also indicated that the patient developed severe induration, erythema, and swelling at the injection site followed by shaking chills, fever, and local cellulitis. There was no illness at the time of vaccination. It was reported that the patient was seen as an outpatient and was treated with an oral antibiotics. It was also reported that the patient recovered on an unspecified date. The reporter considered the patient's experiences to be an important medical event (OMIC). There was no product quality complaint involved. Additional information has been requested.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Back pain, CSF test abnormal, Erythema, Guillain-Barre syndrome, Hypotonia
Clinical narrative: 1/28/05 PM: ascending redness left elbow then from fingertips. 2/8/05 Increasing pain down lower back to thoracic spine. 2/8/05 Admitted to hospital; afebrile. MRI brain negative, C-spine x-ray negative, T-spine  x-ray negative, C-reactive protein 0.8.   03/01/05 Hospital Discharge summary for 2/8-2/14/2005. FINAL DX:  Likely Guillain -Barre syndrome; findings significant for Discharge summary states perioral weakness, persisting pain in back, loss of deep tendon reflexes with progressive lower extremity weakness.  Neuro consult done.  She had improvement with IVIG therapy and was discharged home after 5 days' therapy.         Follow up 7/27/05: Per phone call from RN on 7/20/05: Patient no longer has numbness or weakness (her presenting symptoms). She is back at work, full duty, and is no longer receiving physical therapy. Patient apparently was treated with IVIG. Her physician ordered lab tests (immune markers) and according to the patient, one of the immune markers is still low. Her physician will continue to monitor. The patient was experiencing a lot of flu-like symptoms, but has had none for the past 3 to 4 weeks.
Age: 54.0
Sex: F
Vaccine: FLU3
Symptoms: Influenza like illness
Clinical narrative: 1/28/05 PM: ascending redness left elbow then from fingertips. 2/8/05 Increasing pain down lower back to thoracic spine. 2/8/05 Admitted to hospital; afebrile. MRI brain negative, C-spine x-ray negative, T-spine  x-ray negative, C-reactive protein 0.8.   03/01/05 Hospital Discharge summary for 2/8-2/14/2005. FINAL DX:  Likely Guillain -Barre syndrome; findings significant for Discharge summary states perioral weakness, persisting pain in back, loss of deep tendon reflexes with progressive lower extremity weakness.  Neuro consult done.  She had improvement with IVIG therapy and was discharged home after 5 days' therapy.         Follow up 7/27/05: Per phone call from RN on 7/20/05: Patient no longer has numbness or weakness (her presenting symptoms). She is back at work, full duty, and is no longer receiving physical therapy. Patient apparently was treated with IVIG. Her physician ordered lab tests (immune markers) and according to the patient, one of the immune markers is still low. Her physician will continue to monitor. The patient was experiencing a lot of flu-like symptoms, but has had none for the past 3 to 4 weeks.
Age: 39.0
Sex: M
Vaccine: FLU3
Symptoms: Hot flush, Hypoaesthesia, Myalgia, Nausea, Paraesthesia
Clinical narrative: 20 minutes after receiving had a hot flash, nausea, ached all up her neck and ear and fingers were tingling and numb. Took Tyl and hot bath, felt better, by next AM was fine.
Age: 49.0
Sex: M
Vaccine: FLU3
Symptoms: Headache, Medication error
Clinical narrative: States was given 2 injections. States he was told the 1st shot was full of air and was then given an injection with serum. Had HA 1 1/2 days after shot, denies N/V, numbness/tingling.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Rash papular
Clinical narrative: Pt reports she noticed sporadic itching on left arm 4 days post vaccine admin. Today she has 5 small papules (2 2mm wide) confluent on left deltoid. No swelling, redness or pustules noted. Given Benadryl and hydrocortisone cream. Will call if needed.
Sex: F
Vaccine: FLU3
Symptoms: Feeling hot, Injection site erythema, Injection site mass, Injection site pain
Clinical narrative: Where shot was given red hot, hard, sore to touch, that night or next AM 9x9cm, no SOB, no H/A. Give Rx for Cephalexin 500mg 1 tab PO bid # 20 Medrol dose pack
Age: 43.0
Sex: F
Vaccine: FLU3
Symptoms: Fatigue, Injection site reaction, Pruritus
Clinical narrative: 11:30AM received flu shot 30-40 min ago, has reaction to skin under skin and pruritic, no SOB. On Advair, Singulair, Maxair, allergy shots, Fosamax, Topramax, BCP, lungs-CTA, BP 130/90 given Benadryl 50mg mm 11:35am, called 3:15 pt felt better, is tired, no SOB.
Age: 1.39
Sex: F
Vaccine: DTAPHEPBIP, FLU3, HIBV, MMR, PNC
Symptoms: Pyrexia, Rash morbilliform
Clinical narrative: Fever and morbilliform rash
Age: 22.0
Sex: M
Vaccine: ANTH, ANTH, ANTH
Symptoms: Atrial fibrillation, Dizziness, Fatigue, Heart rate increased, Similar reaction on previous exposure to drug
Clinical narrative: Pt contacted the vaccine healthcare center in order to file a report for atrial fibrillation he developed following receipt of the anthrax vaccine in 1999. He was in her usual state of good health when he received the vaccine and received no other vaccines simultaneously. He received Anthrax Vaccinations #1-3 on 3/25/99, 4/12/99, and 4/29/99. He reports after after shot he experienced episodes of rapid heart beat. He does not recall the time of the exact onset of the episodes related to receipt of the individual vaccine, but that they started after #1 and were intermittent. He reports they would last 30 sec to 20 minutes, were often accompanied by lightheadedness and were not related to activity. They did not cause him a particular problem and he ignored the episodes and did not seek medical care. However after Anthrax #4 on 9/29/99, he experienced an tachycardic episode that lasted 4 hours. He became concerned at this and sought treatment at an ER. He was subsequently evaluated by several military and civilian cardiologists and diagnosed with atrial fibrillation. He was placed on medication and was temporarily retired from the military in 2000. He also reports that sometime in 2000 he began to experience significant fatigue compared to his previous energy level.
Age: 22.0
Sex: M
Vaccine: ANTH, ANTH, ANTH
Symptoms: Tachycardia
Clinical narrative: Pt contacted the vaccine healthcare center in order to file a report for atrial fibrillation he developed following receipt of the anthrax vaccine in 1999. He was in her usual state of good health when he received the vaccine and received no other vaccines simultaneously. He received Anthrax Vaccinations #1-3 on 3/25/99, 4/12/99, and 4/29/99. He reports after after shot he experienced episodes of rapid heart beat. He does not recall the time of the exact onset of the episodes related to receipt of the individual vaccine, but that they started after #1 and were intermittent. He reports they would last 30 sec to 20 minutes, were often accompanied by lightheadedness and were not related to activity. They did not cause him a particular problem and he ignored the episodes and did not seek medical care. However after Anthrax #4 on 9/29/99, he experienced an tachycardic episode that lasted 4 hours. He became concerned at this and sought treatment at an ER. He was subsequently evaluated by several military and civilian cardiologists and diagnosed with atrial fibrillation. He was placed on medication and was temporarily retired from the military in 2000. He also reports that sometime in 2000 he began to experience significant fatigue compared to his previous energy level.
Age: 22.0
Sex: M
Vaccine: ANTH, ANTH, ANTH
Symptoms: Arthralgia, Atrial fibrillation, Dizziness, Fatigue, Heart rate increased
Clinical narrative: Pt contacted the vaccine healthcare center in order to file a report for atrial fibrillation he developed following receipt of the anthrax vaccine in 1999. He was in her usual state of good health when he received the vaccine and received no other vaccines simultaneously. He received Anthrax Vaccinations #1-3 on 3/25/99, 4/12/99, and 4/29/99. He reports after after shot he experienced episodes of rapid heart beat. He does not recall the time of the exact onset of the episodes related to receipt of the individual vaccine, but that they started after #1 and were intermittent. He reports they would last 30 sec to 20 minutes, were often accompanied by lightheadedness and were not related to activity. They did not cause him a particular problem and he ignored the episodes and did not seek medical care. However after Anthrax #4 on 9/29/99, he experienced an tachycardic episode that lasted 4 hours. He became concerned at this and sought treatment at an ER. He was subsequently evaluated by several military and civilian cardiologists and diagnosed with atrial fibrillation. He was placed on medication and was temporarily retired from the military in 2000. He also reports that sometime in 2000 he began to experience significant fatigue compared to his previous energy level.
Age: 22.0
Sex: M
Vaccine: ANTH, ANTH, ANTH
Symptoms: Somnolence
Clinical narrative: Pt contacted the vaccine healthcare center in order to file a report for atrial fibrillation he developed following receipt of the anthrax vaccine in 1999. He was in her usual state of good health when he received the vaccine and received no other vaccines simultaneously. He received Anthrax Vaccinations #1-3 on 3/25/99, 4/12/99, and 4/29/99. He reports after after shot he experienced episodes of rapid heart beat. He does not recall the time of the exact onset of the episodes related to receipt of the individual vaccine, but that they started after #1 and were intermittent. He reports they would last 30 sec to 20 minutes, were often accompanied by lightheadedness and were not related to activity. They did not cause him a particular problem and he ignored the episodes and did not seek medical care. However after Anthrax #4 on 9/29/99, he experienced an tachycardic episode that lasted 4 hours. He became concerned at this and sought treatment at an ER. He was subsequently evaluated by several military and civilian cardiologists and diagnosed with atrial fibrillation. He was placed on medication and was temporarily retired from the military in 2000. He also reports that sometime in 2000 he began to experience significant fatigue compared to his previous energy level.